Broccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast Biopsy

Completed · Phase 2 · Has a placebo group

Conditions studied: Breast Cancer, Precancerous Condition

In brief

RATIONALE: Broccoli sprout extract supplements may slow the growth of tumor cells or abnormal cells and may be an effective treatment for ductal carcinoma in situ and/or atypical ductal hyperplasia. PURPOSE: This randomized phase II trial is studying how well broccoli sprout extract works in treating women with a diagnosis of breast cancer, ductal carcinoma in situ and/or atypical ductal hyperplasia.

Key facts

Study ID
NCT00843167
Run by
OHSU Knight Cancer Institute
People needed
54
Starts
2009-08-01
Expected to finish
2013-12-01
Last updated by the study team
2017-04-27

Who can join

Age: 21 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.